162 related articles for article (PubMed ID: 15956078)
1. Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome.
Barb D; Wadhwa SG; Kratzsch J; Gavrila A; Chan JL; Williams CJ; Karchmer AW; Mantzoros CS
J Clin Endocrinol Metab; 2005 Sep; 90(9):5324-8. PubMed ID: 15956078
[TBL] [Abstract][Full Text] [Related]
2. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
4. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.
Addy CL; Gavrila A; Tsiodras S; Brodovicz K; Karchmer AW; Mantzoros CS
J Clin Endocrinol Metab; 2003 Feb; 88(2):627-36. PubMed ID: 12574192
[TBL] [Abstract][Full Text] [Related]
5. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters.
Chen CC; Li TC; Li CI; Liu CS; Wang HJ; Lin CC
Metabolism; 2005 Apr; 54(4):471-5. PubMed ID: 15798953
[TBL] [Abstract][Full Text] [Related]
6. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.
Lord J; Thomas R; Fox B; Acharya U; Wilkin T
BJOG; 2006 Oct; 113(10):1203-9. PubMed ID: 16753044
[TBL] [Abstract][Full Text] [Related]
7. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.
Lee JH; Chan JL; Yiannakouris N; Kontogianni M; Estrada E; Seip R; Orlova C; Mantzoros CS
J Clin Endocrinol Metab; 2003 Oct; 88(10):4848-56. PubMed ID: 14557464
[TBL] [Abstract][Full Text] [Related]
8. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.
Vozarova de Courten B; Degawa-Yamauchi M; Considine RV; Tataranni PA
Diabetes; 2004 May; 53(5):1279-84. PubMed ID: 15111497
[TBL] [Abstract][Full Text] [Related]
9. Is resistin a link between highly active antiretroviral therapy and fat redistribution in HIV-infected children?
Spagnuolo MI; Bruzzese E; Vallone GF; Fasano N; De Marco G; Officioso A; Valerio G; Volpicelli M; Iorio R; Franzese A; Guarino A
J Endocrinol Invest; 2008 Jul; 31(7):592-6. PubMed ID: 18787374
[TBL] [Abstract][Full Text] [Related]
10. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serum resistin level and adiposity in obese individuals.
Azuma K; Katsukawa F; Oguchi S; Murata M; Yamazaki H; Shimada A; Saruta T
Obes Res; 2003 Aug; 11(8):997-1001. PubMed ID: 12917505
[TBL] [Abstract][Full Text] [Related]
12. Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy.
Sutinen J; Korsheninnikova E; Funahashi T; Matsuzawa Y; Nyman T; Yki-Järvinen H
J Clin Endocrinol Metab; 2003 Apr; 88(4):1907-10. PubMed ID: 12679491
[TBL] [Abstract][Full Text] [Related]
13. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.
Torriani M; Thomas BJ; Barlow RB; Librizzi J; Dolan S; Grinspoon S
J Appl Physiol (1985); 2006 Feb; 100(2):609-14. PubMed ID: 16223978
[TBL] [Abstract][Full Text] [Related]
14. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Lee HC; Kim JM
Metabolism; 2009 Nov; 58(11):1523-9. PubMed ID: 19501863
[TBL] [Abstract][Full Text] [Related]
15. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
[TBL] [Abstract][Full Text] [Related]
16. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
Brown TT; Ruppe MD; Kassner R; Kumar P; Kehoe T; Dobs AS; Timpone J
J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
[TBL] [Abstract][Full Text] [Related]
17. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
[TBL] [Abstract][Full Text] [Related]
18. Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients.
Rossi R; Nuzzo A; Guaraldi G; Squillace N; Orlando G; Esposito R; Lattanzi A; Modena MG
Metabolism; 2009 Jul; 58(7):927-33. PubMed ID: 19394974
[TBL] [Abstract][Full Text] [Related]
19. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.
Goto T; Onuma T; Takebe K; Kral JG
Int J Obes Relat Metab Disord; 1995 Dec; 19(12):841-5. PubMed ID: 8963349
[TBL] [Abstract][Full Text] [Related]
20. Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance.
Pagano C; Marin O; Calcagno A; Schiappelli P; Pilon C; Milan G; Bertelli M; Fanin E; Andrighetto G; Federspil G; Vettor R
J Clin Endocrinol Metab; 2005 Jul; 90(7):4335-40. PubMed ID: 15870134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
